Ostrom QT, Price M, Neff C, et al. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2016–2020. Neuro Oncol 2023;25(Supplement_4):iv1-iv99. https://doi.org/10.1093/neuonc/noad149.
M IJ-K, Snijders TJ, de Graeff A, Teunissen S, de Vos FYF. Prevalence of symptoms in glioma patients throughout the disease trajectory: a systematic review. J Neurooncol 2018;140(3):485–496. https://doi.org/10.1007/s11060-018-03015-9.
Rottgering JG, Belgers V, Kouwenhoven MCM, et al. Frequency and burden of potentially treatable symptoms in glioma patients with stable disease. Heliyon. 2023;9(2):e13278. https://doi.org/10.1016/j.heliyon.2023.e13278.
Article PubMed PubMed Central Google Scholar
Boele FW, Meads D, Jansen F, et al. Healthcare utilization and productivity loss in glioma patients and family caregivers: the impact of treatable psychological symptoms. J Neurooncol. 2020;147(2):485–94. https://doi.org/10.1007/s11060-020-03454-3.
Article PubMed PubMed Central Google Scholar
Haider SA, Asmaro K, Kalkanis SN, et al. The economic impact of glioma survivorship: The cost of care from a patient perspective. Neurology. 2020;95(11):e1575–81. https://doi.org/10.1212/WNL.0000000000010263.
Kumthekar P, Stell BV, Jacobs DI, et al. Financial burden experienced by patients undergoing treatment for malignant gliomas. Neurooncol Pract. 2014;1(2):71–6. https://doi.org/10.1093/nop/npu002.
Article PubMed PubMed Central Google Scholar
Raizer JJ, Fitzner KA, Jacobs DI, et al. Economics of Malignant Gliomas: A Critical Review. J Oncol Pract. 2015;11(1):e59-65. https://doi.org/10.1200/JOP.2012.000560.
Lopez Ramos C, Brandel MG, Steinberg JA, et al. The impact of traveling distance and hospital volume on post-surgical outcomes for patients with glioblastoma. J Neurooncol. 2019;141(1):159–66. https://doi.org/10.1007/s11060-018-03022-w.
Ryan CS, Juhn YJ, Kaur H, et al. Long-term incidence of glioma in Olmsted County, Minnesota, and disparities in postglioma survival rate: a population-based study. Neurooncol Pract. 2020;7(3):288–98. https://doi.org/10.1093/nop/npz065.
Cote DJ, Ostrom QT, Gittleman H, et al. Glioma incidence and survival variations by county-level socioeconomic measures. Cancer. 2019;125(19):3390–400. https://doi.org/10.1002/cncr.32328.
Pritchett JC, Borah BJ, Dholakia R, et al. Patient- and Provider-Level Factors Associated With Telehealth Utilization Across a Multisite, Multiregional Cancer Practice From 2019 to 2021. JCO Oncol Pract. 2023;19(9):750–8. https://doi.org/10.1200/OP.23.00118.
Article PubMed PubMed Central Google Scholar
Shaver J. The State of Telehealth Before and After the COVID-19 Pandemic. Prim Care. 2022;49(4):517–30. https://doi.org/10.1016/j.pop.2022.04.002.
Article PubMed PubMed Central Google Scholar
Monaghesh E, Hajizadeh A. The role of telehealth during COVID-19 outbreak: a systematic review based on current evidence. BMC Public Health. 2020;20(1):1193. https://doi.org/10.1186/s12889-020-09301-4.
Article CAS PubMed PubMed Central Google Scholar
Weiner JP, Bandeian S, Hatef E, Lans D, Liu A, Lemke KW. In-Person and Telehealth Ambulatory Contacts and Costs in a Large US Insured Cohort Before and During the COVID-19 Pandemic. JAMA Netw Open. 2021;4(3):e212618. https://doi.org/10.1001/jamanetworkopen.2021.2618.
Article PubMed PubMed Central Google Scholar
Centers for Medicare & Medicaid Services. Telehealth for Providers: What You Need to Know. (https://www.cms.gov/files/document/telehealth-toolkit-providers.pdf). Accessed 27 May 2024.
Drake C, Lian T, Cameron B, Medynskaya K, Bosworth HB, Shah K. Understanding Telemedicine’s “New Normal”: Variations in Telemedicine Use by Specialty Line and Patient Demographics. Telemed J E Health. 2022;28(1):51–9. https://doi.org/10.1089/tmj.2021.0041.
Article PubMed PubMed Central Google Scholar
United Council for Neurologic Subspecialties. UCNS Diplomate Directory. (https://www.ucns.org/Online/Diplomate_Directory.aspx). Accessed 27 May 2024.
Strowd RE, Dunbar EM, Gan HK, et al. Practical guidance for telemedicine use in neuro-oncology. Neurooncol Pract. 2022;9(2):91–104. https://doi.org/10.1093/nop/npac002.
Article PubMed PubMed Central Google Scholar
Maita KC, Palmieri-Serrano L, Avila FR, et al. Imaging evaluated remotely through telemedicine as a reliable alternative for accurate diagnosis: a systematic review. Heal Technol. 2023;13(3):347–64. https://doi.org/10.1007/s12553-023-00745-3.
Wasilewski A, Mohile N. Tele-neuro-oncology: Current Practices and Future Directions. Curr Oncol Rep. 2022;24(1):99–103. https://doi.org/10.1007/s11912-021-01176-x.
Article PubMed PubMed Central Google Scholar
Sirintrapun SJ, Lopez AM. Telemedicine in Cancer Care. Am Soc Clin Oncol Educ Book. 2018;38:540–5. https://doi.org/10.1200/EDBK_200141.
Worster B, Swartz K. Telemedicine and Palliative Care: an Increasing Role in Supportive Oncology. Curr Oncol Rep. 2017;19(6):37. https://doi.org/10.1007/s11912-017-0600-y.
Haemmerle R, Paludo J, Haddad TC, Pritchett JC. The Growing Role of Digital Health Tools in the Care of Patients with Cancer: Current Use, Future Opportunities, and Barriers to Effective Implementation. Curr Oncol Rep. 2024. https://doi.org/10.1007/s11912-024-01534-5.
Pritchett J, Paludo J, Haemmerle R, et al. Care utilization and satisfaction among patients with cancer with neutropenic fever managed by a remote patient monitoring (RPM) program. JCO Oncology Practice 2023;19(11_suppl):572–572. https://doi.org/10.1200/OP.2023.19.11_suppl.572.
Pritchett JC, Paludo JC, Borah BJ, Haddad TC. Remote Patient Monitoring to Transform Management of Febrile Neutropenia in Cancer Patients. NEJM Catalyst 2024;5(4):CAT.23.0365. https://doi.org/10.1056/CAT.23.036.
Mayo Clinic. Remote Cognitive Assessment Battery and Wearable Device Monitoring Platform While Assessing the Impact of Metformin in Patients With History of Cranial Radiation Therapy. (https://www.clinicaltrials.gov/study/NCT06377696). Acccessed 27 May 2024.
United States Government Accountability Office. Health information technology: HHS should assess the effectiveness of its efforts to enhance patient access to and use of elecronic health information. (https://www.gao.gov/assets/gao-17-305.pdf). Accessed 27 May 2024.
Bressman E, Werner RM, Cullen D, et al. Expiration of State Licensure Waivers and Out-of-State Telemedicine Relationships. JAMA Netw Open. 2023;6(11):e2343697. https://doi.org/10.1001/jamanetworkopen.2023.43697.
Article PubMed PubMed Central Google Scholar
Schwamm LH, Holloway RG, Amarenco P, et al. A review of the evidence for the use of telemedicine within stroke systems of care: a scientific statement from the American Heart Association/American Stroke Association. Stroke. 2009;40(7):2616–34. https://doi.org/10.1161/STROKEAHA.109.192360.
AJMC Staff. A Timeline of COVID-19 Developments in 2020. (https://www.ajmc.com/view/a-timeline-of-covid19-developments-in-2020). Accessed 27 May 2024.
National Weather Service. Rochester Climate Summary for 2023. (https://www.weather.gov/arx/rst2023). Accessed 27 May 2024.
Vanderbeek AM, Rahman R, Fell G, et al. The clinical trials landscape for glioblastoma: is it adequate to develop new treatments? Neuro Oncol. 2018;20(8):1034–43. https://doi.org/10.1093/neuonc/noy027.
Article PubMed PubMed Central Google Scholar
Sener U, Islam M, Webb M, Kizilbash SH. Antiangiogenic exclusion rules in glioma trials: Historical perspectives and guidance for future trial design. Neurooncol Adv 2024;6(1):vdae039. https://doi.org/10.1093/noajnl/vdae039. Accessed 27 May 2024.
Lee EQ, Chukwueke UN, Hervey-Jumper SL, et al. Barriers to accrual and enrollment in brain tumor trials. Neuro Oncol. 2019;21(9):1100–17. https://doi.org/10.1093/neuonc/noz104.
留言 (0)